APOTHEEK HENNEMAN-VAN EETVELDE
ActiveSummary
APOTHEEK HENNEMAN-VAN EETVELDE has been active since 1984 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €971,099 and a net result of €176,964. Equity has been growing by about 19% per year since 2018. Its solvency ranks better than 61% of 5,036 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 18-12-1984 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2021
- Establishment unit
- 2.025.840.644 9080 Lochristi, since 18-12-1984
- Financial year end
- 31 December
- Peppol
- Reachable since 09-12-2025
Board and ownership
- Henneman PaulienDirector · since 01-10-2023
- Henneman JanDirector · since 02-10-2023
- HENNEVELDEDirector · since 02-10-2023 · permanent representative Van Eetvelde Caroline
- HENNEVELDE99.76%2021 annual accounts of HENNEVELDE
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €545,003
- ▲ 45.2%
- Turnover
- ≈ €2.0m
- estimated
- Profit
- €176,964
- ▲ 193%
- Equity
- €971,099
- ▲ 22.3%
- Total assets
- €2.1m
- ▲ 3.6%
- Employees on 31-12-2025
- 3
- =
- 2025 accounts filed 60 days after the deadline
Score breakdownraises riskLast filed accounts filed 60 days late; 1 of the last 3 accounts lateSector: Retail trade (NACE 47)lowers riskFounded in 1984Size: 2.2 FTE, total assets €2.1mShow the evidence
Checked score
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 61% of them on solvency, 65% on liquidity, 70% on profitability and 74% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 33 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Comparable companies
These companies have the same main activity as APOTHEEK HENNEMAN-VAN EETVELDE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.7m and €2.1m, founded between 1982 and 1990.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTHEEK HENNEMAN-VAN EETVELDE Lochristi | €2.1m | €0.5m |
| APOTHEEK PASBRUG Mechelen | €2.1m | €0.5m |
| APOTHEEK VAN HAUTEKERKE Temse | €1.9m | €0.5m |
| APOTHEEK KESTELYN Ieper | €1.9m | €0.5m |
| HAMPHARMA Tessenderlo-Ham | €2.0m | €0.5m |
| APOTHEEK VRANKEN Kontich | €2.1m | €0.7m |
| APOTHEEK CRAUWELS Tessenderlo-Ham | €1.7m | €0.5m |
Key facts about APOTHEEK HENNEMAN-VAN EETVELDE
- What is the company number of APOTHEEK HENNEMAN-VAN EETVELDE?
- The company number of APOTHEEK HENNEMAN-VAN EETVELDE is 0426.572.841. The VAT number is the same number with BE in front: BE 0426.572.841.
- Where is APOTHEEK HENNEMAN-VAN EETVELDE based?
- The registered office is at Oosteinde 7, 9080 Lochristi.Company details
- What does APOTHEEK HENNEMAN-VAN EETVELDE do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK HENNEMAN-VAN EETVELDE?
- The legal form of APOTHEEK HENNEMAN-VAN EETVELDE is Public limited company (NV).
- When was APOTHEEK HENNEMAN-VAN EETVELDE founded?
- APOTHEEK HENNEMAN-VAN EETVELDE was founded on 18-12-1984.
- Is APOTHEEK HENNEMAN-VAN EETVELDE still active?
- Yes, APOTHEEK HENNEMAN-VAN EETVELDE is an active enterprise in the KBO register.
- How many employees does APOTHEEK HENNEMAN-VAN EETVELDE have?
- APOTHEEK HENNEMAN-VAN EETVELDE had an average of 2.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK HENNEMAN-VAN EETVELDE fall under?
- In its 2021 annual accounts, APOTHEEK HENNEMAN-VAN EETVELDE states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of APOTHEEK HENNEMAN-VAN EETVELDE?
- The turnover in financial year 2025 is ≈ €2.0m. This figure is estimated from the gross margin of €545,003 and 47 comparable companies (NACE 477). It probably lies between €1.5m and €3.3m.
- Is APOTHEEK HENNEMAN-VAN EETVELDE profitable?
- In financial year 2025, APOTHEEK HENNEMAN-VAN EETVELDE made a profit of €176,964.
- Where can I find the annual accounts of APOTHEEK HENNEMAN-VAN EETVELDE?
- APOTHEEK HENNEMAN-VAN EETVELDE filed 41 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK HENNEMAN-VAN EETVELDE due?
- APOTHEEK HENNEMAN-VAN EETVELDE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.